EP-201

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEP-201

Drug Alias NameTh1-selective IGFBP-2-modulating ovarian cancer vaccineEP-201

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionTh1 cells stimulants

TargetsNot applicable

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEpithany

China Registration ClassN/A

Active CompaniesEpithany

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

ATC CodeN/A